Institutional Cluster

ARWR

ARROWHEAD PHARMACEUTICALS, INC.
MIXED
Impact 5/10
Horizonweeks Processed22d 12h ago
Institutional cluster: 42 buyers, 43 sellers (mixed)
Actionable Insight ◆ Mixed

The Norges Bank entry is a strong vote of confidence, but the broad-based trimming by quant funds and mega-passive managers, combined with zero insider buying, creates a mixed signal. Monitor for any catalyst (pipeline data, partnership news) that could explain the sovereign wealth fund's conviction. The 45-day 13F reporting lag means these positions may already be adjusted — watch for subsequent filings and price action for confirmation.

DirectionMixed
Confidencemedium
Horizonweeks
Latest settled — T+5d
ARWR ▼ -18.15% at T+5d
NEUTRAL call ✗ call lost -18.15% · α vs SPY -17.65% · entry $82.76 → $67.74
Next anchor: T+20d in 6d
Latest observation: T+15 -27.33% FF3 residual α
Entry anchored
Sep 10, 2026
via day open
T+1d
+0.11%
call +0.11% · α -0.74%
$82.85
settled 21d ago
T+5d
-18.15%
call -18.15% · α -17.65%
$67.74
settled 15d ago
T+20d
—
call — · α —
—
in 6d
T+60d
—
call — · α —
—
in 2mo

Executive Summary

ARWR saw a mixed institutional cluster in Q2 2026 with 42 buyers accumulating $452.7M and 43 sellers reducing by $147.6M. The most notable event was Norges Bank taking a massive new $317.6M position, while several quant and mega-passive funds (D.E. Shaw, RenTech, Goldman Sachs, UBS) trimmed significantly. The net buying of $305.1M is dominated by the sovereign wealth fund's entry, but the broad-based selling by 43 institutions and zero insider buying (confluence score 25/100, divergent) tempers conviction. Historical calibration shows past neutral reports on ARWR had poor T+20 outcomes (-5.69% avg), and the score-7 observed P of 43% suggests caution on bullish scoring. The amplifier verdict for inst-earnings + inst-offering context supports moderate impact, but the lack of insider corroboration and mixed direction warrants a neutral-to-mildly-bullish stance.

Key Financial Metrics

Direction
mixed
Buy Value
$522.6M
Sell Value
$147.6M
Net Flow
$305.0M

Institutional Positions

Net institutional flow: $305.0M

▲ Buyers (42)

InstitutionActionChangePosition ValueValue Δ
Norges BankNEW—$317.6M$317.6M
Dimensional Fund AdvisorsADD+94.2%$96.3M$58.2M
MillenniumNEW—$26.8M$26.8M
Susquehanna International GroupADD+57.5%$48.6M$24.9M
Jane Street GroupDOUBLED+1143.8%$16.0M$15.0M

▼ Sellers (43)

InstitutionActionChangePrev ValueValue Δ
D.E. ShawTRIM-63.5%$74.2M-$39.1M
Pictet Asset Management HoldingTRIM-55%$79.6M-$32.9M
RenTechTRIM-54.8%$65.0M-$26.8M
Goldman SachsTRIM-33.9%$109.1M-$15.4M
UBSTRIM-35.5%$83.8M-$13.6M

Key Facts

  • 42 institutional buyers added $452.7M in new ARWR positions in Q2 2026
  • 43 institutional sellers reduced holdings by $147.6M
  • Norges Bank initiated a new $317.6M position (3.90M shares), the largest single move
  • D.E. Shaw trimmed 63.5% (-$39.1M), RenTech trimmed 54.8% (-$26.8M)
  • Goldman Sachs, UBS, and Northern Trust each trimmed 28-36% of their positions
  • Zero open-market insider buying during the quarter (confluence score 25/100, divergent)
  • Net institutional inflow of ~$305M, but broad-based selling by 43 funds creates mixed signal

Financial Impact

Net institutional inflow of approximately $305M (42 buyers adding $452.7M vs 43 sellers reducing $147.6M), dominated by Norges Bank's $317.6M new position

institutional ownershipfloatnet institutional flow

Risk Factors

  • 13F data is 45+ days stale; positions may have been unwound since quarter-end
  • Broad selling by 43 institutions suggests lack of broad conviction despite Norges Bank's large entry
  • Zero insider buying and divergent confluence score (25/100) weakens the bullish signal
  • Historical calibration shows score-7 reports on this segment have only 43% observed P (net negative expected alpha)

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-ARWR-2026-Q2
3 reports for ARWR
Performance horizon
Filters
Rows
Reports for ARWR — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
Institutional Cluster
MIXED ★ 5/10
$82.76 $67.74▼ −18.15%▼ −17.65%—
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$87.47 $88.59▲ +1.28%▲ +0.17%—
Jun 16, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$81.04 $79.81▼ −1.52%▼ −0.48%—
Showing 3 of 3

US Market Status

Market Closed — Opens Mon (65h 6m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 10, 2026